Guggenheim Initiates Coverage On Verastem with Buy Rating, Announces Price Target of $13
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Michael Schmidt has initiated coverage on Verastem (NASDAQ:VSTM) with a Buy rating and set a price target of $13.
September 30, 2024 | 11:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim has initiated coverage on Verastem with a Buy rating and a price target of $13, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target by a reputable analyst can lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100